Advanced imaging technology will support patient enrolment and provide detailed analysis of anatomical lung changes, helping evaluate the efficacy of CAL101 in idiopathic pulmonary fibrosis.
Over 260 exhibitors and a world-class scientific program will spotlight the latest technologies driving personalized medicine, advanced analytics, and digital transformation in the lab.
Company joins forces with Thermo Fisher Scientific to develop integrated workflow combining Syncell’s Microscoop technology and Thermo Fisher’s Orbitrap Astral mass spectrometer series
A new imaging-guided sample preparation approach enables unbiased identification of all proteins within precisely defined tissue regions, expanding opportunities for drug discovery.